| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $54.32B | -6.4% |
| Cost of Revenue | $20.41B | +17.2% |
| Gross Profit | $8.60B | — |
| R&D Expense | $7.67B | +17.9% |
| SG&A Expense | $12.87B | -15.6% |
| Operating Income | $12.76B | -29.6% |
| Interest Expense | $2.22B | -0.3% |
| Pre-tax Income | $6.25B | -53.6% |
| Income Tax | $1.38B |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $12.81B | +39.3% |
| Short-term Investments | $2.0M | -92.9% |
| Accounts Receivable | $11.15B | -0.9% |
| Inventory | $4.10B | +14.5% |
| Current Assets | $33.00B | +15.9% |
| Total Assets | $134.71B | -2.9% |
| Current Liabilities | $37.84B | +28.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $22.84B | -8.4% |
| Capital Expenditures | $777.0M | +11.8% |
| Investing Cash Flow | -$2.01B | -222.5% |
| Financing Cash Flow | -$17.22B | +30.6% |
| Free Cash Flow | $22.06B | -9.0% |
| -15.6% |
| Net Income | $4.86B | -58.9% |
| EPS (Basic) | $2.73 | -58.9% |
| EPS (Diluted) | $2.72 | -59.0% |
| Long-term Debt |
| $59.24B |
| -6.2% |
| Stockholders' Equity | $10.36B | -40.0% |